Benchmarking cross-species-nominated drug candidates targeting human granulosa cell aging

A 12-month, $10k in vitro pilot to test ASGARD-nominated drug repurposing candidates (led by dexamet…

• RFP Fit
• Rigorous Design
• Single Model
• Limited Senescence Markers